• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 4. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Dimethoxybenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Methoxybenzenes Dimethoxybenzenes

Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1) and its Significance in Modern Chemical Research

Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1), with the CAS number 1472-54-4, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This compound, often referred to by its systematic name, represents a unique structural motif that has garnered attention due to its potential biological activities and its utility in the synthesis of more complex molecules. The presence of both methoxy and phenylmethyl (benzyl) substituents on an amine backbone suggests a rich chemical space for interaction with biological targets, making it a valuable scaffold for drug discovery efforts.

The hydrochloride salt form of this compound enhances its solubility in aqueous systems, which is a critical factor in pharmaceutical applications. This solubility profile facilitates its use in various biochemical assays and in the formulation of drug delivery systems. The compound's structure also suggests potential interactions with enzymes and receptors, which are key considerations in the design of novel therapeutic agents.

Recent research has highlighted the importance of amine derivatives in the development of pharmacological agents. Specifically, compounds containing dimethoxy substitution patterns have shown promise in modulating neurotransmitter systems. For instance, studies have indicated that similar structural motifs may influence the activity of monoamine oxidase enzymes, which are crucial in the metabolism of neurotransmitters such as dopamine and serotonin. The Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1) compound could potentially serve as a lead molecule or intermediate in the synthesis of agents designed to interact with these enzymes.

In addition to its potential role in central nervous system disorders, this compound may also find applications in the treatment of other diseases. Its structural features suggest that it could interact with various biological targets, including kinases and other enzymes involved in cell signaling pathways. The phenylmethyl group, in particular, is a common feature in many bioactive molecules and has been shown to enhance binding affinity to biological targets due to its ability to form multiple non-covalent interactions.

The synthesis of this compound involves multi-step organic reactions that showcase the expertise required in pharmaceutical chemistry. The introduction of methoxy groups at the 3 and 4 positions of the benzene ring requires precise control over reaction conditions to ensure high yield and purity. Similarly, the attachment of the phenylmethyl group via an amide bond necessitates careful optimization to minimize side reactions. These synthetic challenges highlight the importance of advanced chemical techniques and methodologies in the preparation of complex molecules like Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1).

Advances in computational chemistry have also played a significant role in understanding the potential biological activity of this compound. Molecular modeling studies can predict how Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1) interacts with biological targets at the atomic level. These predictions can guide experimental efforts by identifying key binding sites and optimizing molecular properties for improved efficacy. Additionally, computational methods can help assess potential toxicity profiles early in the drug discovery process, thereby reducing the risk of failures later in development.

The hydrochloride salt form of this compound not only improves solubility but also enhances stability during storage and transport. This stability is crucial for ensuring that pharmaceutical products remain effective throughout their shelf life. Furthermore, the salt form can influence how the compound is absorbed and distributed within an organism upon administration. These factors are critical considerations when developing new drugs and require thorough investigation through preclinical studies.

In conclusion, Benzeneethanamine,3,4-dimethoxy-N-(phenylmethyl)-, hydrochloride (1:1) represents a promising compound with significant potential in pharmaceutical research. Its unique structural features make it a valuable scaffold for developing new therapeutic agents targeting various diseases. The advancements in synthetic chemistry and computational methods continue to enhance our ability to explore and optimize such compounds for clinical applications. As research progresses, it is likely that more insights into the biological activity and therapeutic potential of this compound will emerge.

• 40171-93-5(3-(3,4-dimethoxy-benzylamino)-propan-1-ol)
• 4579-60-6(N-(p-Hydroxyphenethyl)-N-(3-hydroxy-4-methoxy)benzylamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)